57.48
+0.15
+(0.26%)
As of 1:39:32 PM EST. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 21 | 15 | 24 | 25 |
Avg. Estimate | 0.94 | 1.33 | 5.2 | 6.04 |
Low Estimate | 0.45 | 1.01 | 4.68 | 5.43 |
High Estimate | 1.29 | 1.73 | 5.82 | 7.49 |
Year Ago EPS | 2.12 | 1.31 | 8.74 | 5.2 |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 18 | 10 | 24 | 24 |
Avg. Estimate | 96.9B | 92.96B | 371.65B | 386.44B |
Low Estimate | 94.15B | 91.05B | 367.97B | 370.54B |
High Estimate | 98.97B | 95.02B | 374.07B | 402.43B |
Year Ago Sales | 93.81B | 88.44B | 357.78B | 371.65B |
Sales Growth (year/est) | 3.29% | 5.12% | 3.88% | 3.98% |
Earnings History
Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
---|---|---|---|---|
EPS Est. | 1.99 | 1.7 | 1.73 | 1.46 |
EPS Actual | 2.12 | 1.31 | 1.83 | 1.09 |
Difference | 0.13 | -0.39 | 0.1 | -0.37 |
Surprise % | 6.59% | -22.79% | 5.95% | -25.23% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0.94 | 1.33 | 5.2 | 6.04 |
7 Days Ago | 0.93 | 1.33 | 5.22 | 6.08 |
30 Days Ago | 0.99 | 1.34 | 5.32 | 6.22 |
60 Days Ago | 1.06 | 1.31 | 5.34 | 6.4 |
90 Days Ago | 1.7 | 1.48 | 6.44 | 7.27 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | 1 | -- | -- |
Up Last 30 Days | -- | 1 | -- | -- |
Down Last 7 Days | 1 | -- | 2 | 1 |
Down Last 30 Days | 4 | 2 | 7 | 5 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
CVS | -55.89% | 1.85% | -40.47% | 16.19% |
S&P 500 | 9.90% | 11.00% | 14.01% | 13.54% |
Upgrades & Downgrades
Maintains | Evercore ISI Group: Outperform to Outperform | 1/27/2025 |
Maintains | Truist Securities: Buy to Buy | 1/6/2025 |
Upgrade | Deutsche Bank: Hold to Buy | 12/3/2024 |
Maintains | TD Cowen: Buy to Buy | 11/25/2024 |
Maintains | Piper Sandler: Overweight to Overweight | 11/25/2024 |
Reiterates | Truist Securities: Buy to Buy | 11/20/2024 |
Related Tickers
UNH UnitedHealth Group Incorporated
537.62
-0.90%
HUM Humana Inc.
299.49
-1.19%
ELV Elevance Health, Inc.
401.52
-0.96%
CI The Cigna Group
304.63
+0.60%
CLOV Clover Health Investments, Corp.
4.4700
-2.61%
CNC Centene Corporation
64.07
-1.00%
OSCR Oscar Health, Inc.
16.86
+3.56%
MOH Molina Healthcare, Inc.
304.69
-0.89%
ALHC Alignment Healthcare, Inc.
15.28
+0.39%
NEUE NeueHealth, Inc.
7.32
-0.41%